WeDaita

Research Digest

AI-curated papers, approvals, clinical compounds, and disclosures from drug discovery's leading sources.

Scored for relevance by WeDaita AI · Updated weekly · Not editorial content

Computational and medicinal chemistry advances, approved drugs, and clinical pipeline entries across the full drug design lifecycle.

  • Literature — AI-driven molecular generation, virtual screening, ADMET prediction, and structure-based design from PubMed, arXiv, and Semantic Scholar
  • FDA Approval — Recently approved small-molecule drugs (NDA approvals) sourced from openFDA
  • Clinical Compound — Phase I–III candidates from ChEMBL — molecules in active clinical development not yet approved
  • Disclosure — New molecular series and compound profiles curated by Drug Hunter
  • Patent — Drug Hunter Patent Gazette roundups with expert annotations on assignees, targets, and key novelty claims
  • Industry News — Company announcements, funding rounds, and biotech media coverage
Literature
ArchSpace: Recording, Reviewing, and Referencing LLM Architecture Research
Nov 12, 2026 · wedaita-biomed-mcp · Jie Wang; Tong Zhu; JiaHao Kuang; Zhe Xu; Yunkai Chai
Literature
ProtoVis-Nav: Prototypical Visual Imagination for Visual-Spatial Aligned UAV Navigation
Nov 12, 2026 · wedaita-biomed-mcp · Guangyuan Sui; Yunzhong Hou; Chi Harold Liu
Literature
TTB: Test-time Baking for Efficient Rendering of Decoder-only View Synthesis Models
Nov 12, 2026 · wedaita-biomed-mcp · Chin-Yang Lin; Ryo Hachiuma; Jaesung Choe; Min-Hung Chen; Y…